Mounjaro (tirzepatide): A novel dual GIP and GLP-1 receptor agonist, showing significant efficacy in both type 2 diabetes and weight loss, available for prescription under specific medical criteria
Alcohol doesn't degrade the peptides
McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH
Unlike gastroparesis caused by irreversible nerve damage (such as that seen in long-standing diabetes or post-surgical complications), the delayed gastric emptying induced by Ozempic results from ongoing receptor activation
During this time, we determine the best dosage for you and then adjust the price accordingly based on your specific needs